PharmaSwiss is a privately owned speciality pharmaceutical company whereas 58% is owned by PharmaSwiss insiders, 29% by HBM Bioventures (Swiss based Venture Capital firm, one of the largest healthcare dedicated investors in Europe), and 13% by Enterprise Investors (Polish Enterprise Fund VI, oldest and largest country based private equity company in CEE).
Ownership Structure
HBM BioVentures - Swiss based Venture Capital firm - One of the largest healthcare dedicated investors in Europe
Enterprise Investors - Polish Enterprise Fund VI - Oldest and largest country based private equity company in CEE